FEB 28, 2019 10:00 AM PST

Optimizing GI Testing: Molecular Diagnostic Testing for Common Stool Pathogens

Sponsored by: BD
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Professor of Pathology and Laboratory Medicine, Scientific Director and Microbiology, Cedars-Sinai Medical Center
    Biography

      Dr. Morgan has over 30 years of laboratory experience first as a bench technologist and then laboratory director. Her professional focus has been antimicrobial stewardship, Clostridium difficile diagnostic strategies and infection control measures, and application of molecular methods to the microbiology laboratory. These interests have led to over 100 abstracts and publications. Dr. Morgan earned her BS in Medical Technology at the University of Oklahoma, and her PhD in Medical Microbiology and Immunology at the University of Oklahoma Health Sciences Campus. She obtained a Fellowship in Clinical Microbiology at the Mayo Clinic (Rochester, MN). She is certified by the American Board of Medical Microbiology. She has been twice awarded the Golden Apple Award for teaching Medical students, Pathology residents and Infectious Disease Fellows at Cedars-Sinai medical center. She has spoken at numerous regional and national meetings, presented numerous national webinars, and she is the past president of her local ASM chapter (SCASM), and hosts a microbiology blog on the internet for the review of microbiology, "Microbes with Dr. Morgan". Dr. Morgan is a Professor in Pathology and Laboratory Medicine and Director of the Microbiology Laboratory at Cedars-Sinai Medical Center, where she has worked for 34 years.


    Abstract
    DATE:   February 28, 2019
    TIME:    10:00am PST, 1:00pm EST
     
    Over the past few years the gastroenterology diagnostic market has witnessed an increase in commercial multiplex diagnostic assays for the detection of a large array of enteric pathogens. These multiplex assays differ in many aspects, one important difference being the number of enteric pathogens that the assays detect. Updated IDSA/SHEA guidelines for the management of infectious diarrhea describe a targeted approach, directing proper test utilization for the diagnosis of infectious diarrhea. The guidelines can assist with the development of targeted testing algorithms to diagnose the enteric pathogens most likely causing disease. This patient centric targeted testing approach can be supported by using the BD MAX ™ system, which uses separate testing panels for the detection of C. difficile, bacterial, parasitic, and viral pathogens.
     
    By the end of this presentation one will:
    • Understand how updated guidelines can be used to direct patient testing for infections diarrhea
    • Recognize the value and ability to target testing for C. difficile, bacterial, parasitic and viral pathogens.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more